The Iatrogenic State: Constitutional Rights, Regulatory Dogmatism, and the Legal Imperative for Restorative Healing and Justice
I. Introduction: The Crisis of Authority and the Demand for Constitutional Sanctuary
1.1. Iatrogenic Harm as the Catalyst for Legal Dissent
The foundation of the argument for robust constitutional protection against mandatory health policies rests on the demonstrable capacity of the regulated medical system to inflict profound harm—a phenomenon known as iatrogenesis. Iatrogenic harm refers to injury resulting from medical care, whether or not that injury rises to the level of negligence.[1] The premise begins with the concept of “epidural drug trauma,” an outcome that, while medical rare, underscores the inherent psychological (and future) risk present even in routine medical procedures.[2] Epidural analgesia is widely used, administered to approximately 70% to 75% of women in labor.[2] Obviously, improper administration can constitute medical negligence, allowing for recovery of damages under a medical malpractice claim[2, 3], but what this work explores is the fact that a drug use psychological can create a drug memory, which when held like traumatic memory could become a psychological feature in the future.
Specific injuries resulting from epidural errors can be severe, including nerve damage leading to lifelong pain, dural puncture causing lasting headaches and potentially fatal consequences, spinal cord infarction, neuropathy, and even partial or complete paralysis.[3] These outcomes represent concrete “drug trauma,” directly arising from the regulated, professional practice of medicine. Such incidents fundamentally challenge the ethical duties of beneficence and non-maleficence [4] and contribute to America’s alarmingly high and increasing maternal mortality rates relative to other industrialized nations.[5] The failure to adequately inform patients of material risks can also lead to claims of lack of informed consent, which is a legally recognized document and process central to both medical ethics and healthcare law.[5, 6]
When the institutional structure designed to heal and protect (the medical profession) is proven capable of inflicting severe, systemic, and sometimes negligent harm, it creates an autonomy deficit that necessitates individual recourse to the highest legal sanctuary. The realized trauma provides moral and factual justification for invoking constitutional rights, such as religious exemptions, to defend personal physical integrity against future state-mandated interventions. The primary recourse for a patient whose trust has been eroded by institutional failure and moral injury is the maximal assertion of autonomy [7], viewing constitutional sanctuary as the only effective defense against the imposition of mandatory risks.
1.2. Scope and Constitutional Framework: Autonomy, Justice, and the Challenge to Regulatory Paternalism
This scholarly analysis examines how the regulatory state—specifically through occupational licensing regimes and federal drug prohibition (the Controlled Substances Act)—has prioritized scientific dogmatism and economic self-interest over individual constitutional rights and emerging scientific truth. The study posits that systemic medical failures justify a legal challenge spanning three critical constitutional domains: the First Amendment’s Free Exercise Clause (justifying religious refusal of mandates), the Fourteenth Amendment’s Equal Protection and Due Process Clauses (challenging the arbitrary hierarchy of medical professions), and Article I’s Separation of Powers Doctrine (scrutinizing the legitimacy of the “War on Drugs”). The overarching aim is to define a legal and ethical framework for restorative professional practice, grounded in constitutional fidelity and scientific realism.
II. The First Amendment Defense: Religious Exemption as the Last Stand Against Mandated Risk
2.1. The Legal Counterargument: The Religious Freedom Restoration Act (RFRA)
The legal foundation for demanding religious exemptions from generally applicable health mandates stems from the tension between government authority and the fundamental right to free exercise of religion. The Supreme Court’s 1990 decision in Employment Division v. Smith significantly limited religious freedom by holding that neutral, generally applicable laws did not require religious exemptions.[8] In direct response, Congress enacted the Religious Freedom Restoration Act (RFRA) in 1993, explicitly reinstating a higher standard of judicial review for federal actions.[8, 9]
Under RFRA, the government may not substantially burden a person’s exercise of religion unless it demonstrates that the application of the burden “(1) Is in furtherance of a compelling governmental interest; and (2) Is the least restrictive means of furthering that compelling governmental interest”.[9] This stringent test, known as strict scrutiny, mandates that religious liberty occupies a preferred position and cannot be encroached upon unless required by clear and compelling governmental interests “of the highest order”.[10] The constitutional counterargument, therefore, is rooted not merely in moral belief, but in a congressionally mandated legal requirement to preserve religious liberty to the fullest extent possible.[10]
2.2. The Individualized Assessment Exception and Health Policy
The existence of documented iatrogenic harm within the conventional medical system further strengthens the legal necessity of granting religious exemptions. Even in the post-Smith era, strict scrutiny remains applicable in cases involving government action that intentionally burdens religious exercise and, crucially, in programs that allow for individualized assessments.[8]
Medical mandates, such as those governing mandatory vaccination or specific treatments, often include provisions for medical exemptions based on individualized health risks or conditions. This practice of individualized assessment immediately triggers the compelling interest test under RFRA. The assertion that mainstream medical practice, exemplified by the possibility of “epidural drug trauma” [3], presents known, severe, and measurable risks, introduces objective evidence that mandatory adherence to the system is not necessarily benign.
If a patient asserts a religious objection to a mandate, the government must then prove that its public health objective cannot be achieved by exempting that individual—that the policy is the “least restrictive means”.[9] The documented failure of the medical establishment to prevent iatrogenic harm (a breach of the duty of beneficence [4]) fundamentally compromises the government’s claim that its mandated intervention ensures superior public safety. The possibility of trauma resulting from the state-sanctioned medical practice weakens the government’s compelling interest argument and supports the individual’s assertion of religious refusal as a necessary defense of personal integrity against systemic risk.
III. Structural Inequity in Healing: A Legal Critique of the Separate and Unequal Professional Estate
3.1. The Historical Context of State Police Power and Licensing
State professional licensing boards, including State Medical Boards (SMBs), are regulatory bodies established under the states’ unenumerated police power, derived from the Tenth Amendment, to protect the health, safety, and welfare of the citizenry.[11] The Supreme Court confirmed the states’ authority to regulate medicine and other professions via professional licensing boards in Dent v. West Virginia.[11] These state boards hold enormous power, defining the acceptable standards of care, dictating educational requirements (e.g., 4,200 hours for chiropractic licensure) [12], and overseeing disciplinary processes.[13]
3.2. Occupational Licensing as Economic Protectionism
The current structure of healthcare professional regulation has created a hierarchy—a “separate and not equal” professional estate—where certain modalities and practitioners are arbitrarily privileged over others, particularly those in Complementary and Alternative Medicine (CAM).[14] This exclusion is frequently criticized not as a measure of public safety, but as a mechanism of economic protectionism designed to shield established, incumbent providers (historically championed by groups like the American Medical Association) from competition.[14, 15]
Legal challenges to occupational licensing laws often invoke the Equal Protection and Due Process Clauses of the Fourteenth Amendment. While courts typically apply a rational basis review to economic regulations [16], restrictions on occupational freedom that lack a rational connection to public health and are intended primarily to protect the market share of incumbents may fail constitutional scrutiny.[15] Laws such as Certificate of Need (CON) requirements, which necessitate government permission to open a healthcare facility, restrict qualified businesses and physicians and undermine protections for Due Process, Equal Protection, and occupational liberty.[15] The prevalence of these laws suggests that state actors are prioritizing the economic interests of established professionals, which can be legally construed as arbitrary and hostile discrimination under the Equal Protection Clause.[16]
3.3. Professional Speech and the Suppression of Alternatives
The legal conflict over professional hierarchy is further complicated by the First Amendment right to free speech. The medical establishment enforces the standard of care based on the consensus of the “knowledge community”.[17] This authority is often used to compel professionals to “follow the science” as interpreted by the dominant paradigm, sometimes leading to the suppression of scientifically credible alternatives.
Licensing boards attempt to regulate professional conduct, which often involves speech (e.g., advising patients).[18] However, the First Amendment imposes limits on how professional speech can be regulated. Regulations that grant government officials “substantial power to discriminate based on the content or viewpoint of speech” are constitutionally suspect.[19] The systematic exclusion of healing modalities, especially those that conflict with institutional dogma (e.g., the use of cannabis, as discussed in Section IV), can be challenged as a violation of the First Amendment, particularly when professional regulations force specific disclosures or prohibit truthful communication about beneficial, non-standard treatments.[17]
The constitutional vulnerability of these boards lies in the intent behind their regulations. If a regulation is designed primarily to suppress competition and innovation, rather than to protect the public health, it moves beyond legitimate state police power and into the territory of constitutional violation, triggering liability under federal civil rights law.
Table 1 details the primary constitutional vulnerabilities facing state licensing boards that enforce anticompetitive or dogmatic regulations.
Table 1: Constitutional Vulnerabilities of Professional Licensing Boards
| Constitutional Challenge | Legal Doctrine Invoked | Mechanism of Violation |
| Equal Protection Clause (14th Amend.) | Rational Basis/Anti-Competitiveness | Protecting incumbents and creating arbitrary classifications favoring licensed orthodoxy over alternative practitioners.[15, 16] |
| Due Process Clause (5th/14th Amend.) | Occupational Liberty/Vagueness | Arbitrary denial of licensing or suspension based on non-standard practice, stifling innovation or patient choice.[20] |
| First Amendment (Speech/Association) | Professional Speech Doctrine | Mandating specific treatment speech or prohibiting truthful communication about non-standard healing modalities.[17] |
| Section 1983 Liability | Color of State Law | Actions taken by board members that intentionally or recklessly violate an individual’s constitutional rights (e.g., due process in licensing disputes).[21, 22] |
IV. The Scientific-Legal Conflict: Cannabis Prohibition, Endocannabinoid Discovery, and the Flawed Premise of Schedule I
4.1. The Controlled Substances Act and the Legal Fiction of Schedule I
The federal prohibition of cannabis is codified in the Controlled Substances Act (CSA) of 1970, which Congress enacted utilizing its power under the Commerce Clause to regulate interstate commerce.[23, 24] The CSA created a legal framework for classifying regulated substances into five schedules based on their accepted medical use, potential for abuse, and harmfulness.[24] Cannabis (marijuana) was placed in Schedule I, the most restrictive category.
To qualify for Schedule I status, a substance must satisfy three criteria [25]:
1. A high potential for abuse.
2. A lack of accepted safety for use under medical supervision.
3. No currently accepted medical use in treatment in the United States.
This classification, made in 1970, cemented the government’s official point of view that marijuana was an addicting drug “devoid of therapeutic benefits” [26, 27], despite evidence of its extensive medicinal use dating back thousands of years.[28]
4.2. The Dawn of the Endocannabinoid System (ECS) and Scientific Contradiction
The scientific underpinnings of the CSA classification have been fundamentally challenged by decades of research, particularly concerning the discovery and elucidation of the Endocannabinoid System (ECS). Although the structure of the main psychoactive phytocannabinoid, THC, was determined in 1964 [29], the breakthrough discovery came later: the CB1 receptor was identified in 1988, followed by the identification of the first endogenous cannabinoid neurotransmitter (Anandamide) in 1992, and the CB2 receptor in 1993.[30] Research into the ECS, a complex signaling system regulating diverse physiological processes [26], significantly accelerated around 2012, confirming its presence and functionality, particularly in the central nervous system (CB1) and immune cells (CB2).[26, 30]
Scientific consensus now recognizes that modulating the ECS holds significant therapeutic promise. Research indicates potential value in treating certain types of pain, inflammation, epilepsy, spasticity, and eating disorders.[26] The scientific validation of a dedicated, widespread human regulatory system responsive to cannabinoids directly negates the CSA’s statutory requirement of “no currently accepted medical use”.[25, 31] This conflict is underscored by the fact that other controlled substances, such as cocaine, are placed in Schedule II, reflecting a finding that they possess some accepted medical use.[31]
4.3. Administrative Law Challenge to Scientific Arbitrariness
The continued Schedule I classification of cannabis, despite overwhelming scientific evidence regarding the ECS and the therapeutic applications of botanical cannabinoids, creates a direct scientific-legal conflict. The DEA, which administers the CSA, continues to uphold the Schedule I assignment by relying on policy findings that predate modern scientific reality.[27]
The persistence of the “War on a plant that is healing” is rooted in scientific dogmatism codified into law. From an administrative law perspective, the DEA’s refusal to reschedule cannabis, even after receiving internal scientific recommendations, is susceptible to challenge as an action that is “arbitrary and capricious” under the Administrative Procedure Act (APA). The law requires regulatory findings to be grounded in factual evidence. When the foundational scientific premise—the lack of medical utility—is conclusively refuted by the discovery of a major human physiological system (ECS), maintaining the original regulatory finding constitutes an abuse of administrative discretion, directly impeding medical research and patient access.[31]
V. The Constitutional Status of the “War on Drugs”: Separation of Powers and Unauthorized Hostilities
5.1. The Distinction Between Statutory Policy and Constitutional War
The user’s constitutional inquiry addresses whether the “War on Drugs” required a Congressional declaration under the U.S. Constitution. Article I, Section 8, Clause 11 grants Congress the exclusive power to “declare War”.[32, 33] The “War on Drugs,” initiated by President Nixon in 1971 [34], is not a constitutional war; it is a policy initiative enforced primarily through domestic legislation, chiefly the CSA, relying on Congress’s Commerce Clause power.[23] Therefore, the domestic policy campaign did not require a formal declaration of war from Congress.
Congress can, and often does, authorize military action for limited operations short of a full-scale constitutional war through statutory authorizations for the use of military force (AUMFs).[32] Since 1942, Congress has not formally declared war, relying instead on these AUMFs.[33]
5.2. Executive Overreach and the War Powers Resolution
While the domestic component of the “War on Drugs” is statutory, its foreign implementation involving military operations against cartels raises significant separation of powers issues. The executive branch’s use of United States Armed Forces in foreign anti-narcotics campaigns, such as strikes on alleged drug smuggling boats in the Caribbean, has been widely scrutinized.[35, 36]
Congressional members have raised questions regarding the legality of such strikes, pointing out that military force used without specific Congressional authorization may violate the War Powers Resolution of 1973.[35, 36] This act mandates that the president cannot use military force in hostilities without explicit congressional approval, whether through a declaration of war or specific statutory authorization.[36]
The political rhetoric of a “War on Drugs” is critical here. Although it is not a formal war, the language permitted the federal government to adopt a punitive, quasi-military approach that facilitated the massive expansion of federal criminal and regulatory power. This language allowed policymakers to circumvent normal legislative checks and balances applicable to domestic social policy. When the “war” involves international military action, however, the constitutional requirements for authorizing force immediately apply, demonstrating that the executive use of force in this policy area is constantly challenged regarding its legitimacy under Article I authority.[35, 36]
VI. Accountability and Legal Redress: Constitutional Consequences for Professional Violations
6.1. Suing the State Actor: The Application of 42 U.S.C. § 1983
When professions, acting through state licensing boards, violate the constitutional rights of individuals—whether practitioners or patients—the federal legal remedy provided by 42 U.S.C. § 1983 becomes paramount. This statute allows individuals to recover damages when their rights (such as Due Process or Equal Protection) are violated by persons acting “under color of state law”.[20, 21]
State Professional Licensing Boards operate under the authority of state law [11] and are considered state actors. Their members are therefore subject to § 1983 scrutiny for actions that violate constitutional mandates.[19] Boards can incur liability by arbitrarily or discriminatorily enforcing regulations that deny practitioners the due process of law [20, 22] required for licensing or disciplinary actions. This is particularly relevant when boards enforce exclusionary policies rooted in economic protectionism, thereby violating the practitioner’s occupational liberty and Equal Protection rights.[15] Moreover, if boards suppress professional speech regarding scientifically validated alternatives, they risk violating First Amendment rights, transforming their regulatory function into a civil rights violation.[17, 19]
6.2. Iatrogenic Negligence and Compounded Harm
Iatrogenic harm, the injury resulting from medical care [1], may lead to professional negligence claims if the harm results from a deviation from the standard of care.[1] However, current legal structures often fail to deal with the vast majority of medical errors, leaving a gap in accountability.[13]
The legal consequences become more profound when regulatory dogmatism compounds the initial iatrogenic injury. If medical professionals, constrained by scientifically obsolete federal statutes like the CSA Schedule I, are prohibited from using or even recommending healing modalities (such as cannabis, proven to interact with the ECS and offer therapeutic benefits) [26, 28], they are arguably withholding necessary information required for genuine informed consent.[6]
This regulatory suppression of available, safe healing agents constitutes a failure to offer all viable alternatives, potentially compounding the original “drug trauma” experienced by the patient. If the constitutional right to occupational liberty is infringed by anticompetitive licensing laws, and if the scientific basis for excluding alternatives (e.g., Schedule I) is refuted, then the legal framework that forced practitioners to “follow the science” (as interpreted by an outdated policy) has directly contributed to patient harm. In these instances, the liability shifts from individual negligence to systemic regulatory misconduct, where professional standards conflict with constitutional and scientific reality, opening the door for complex civil litigation challenging the boards themselves.
VII. Moral-Ethics and Restorative Justice: A Path to Professional Integrity and Healing
7.1. Reframing Medical Ethics: The Collapse of Paternalism
Medical ethics provides the framework for professional conduct, built upon the four pillars of autonomy, beneficence (the duty to do good), non-maleficence (the duty not to do bad), and justice.[4, 37] Historically, medicine often operated under a paternalistic model, prioritizing the clinician’s view of beneficence over patient autonomy.[7] This model is inherently flawed and prone to error and abuse.[38]
The rise of patient autonomy demands that information flow is guided by values that prevent imbalance and abuse, ensuring that the patient is fully capable of making decisions.[7, 38] Professionals, who fundamentally shape society’s definitions of “healthy/sick” and “legal/illegal” [39], carry a profound moral responsibility to ensure their definitions are rooted in empirical truth and justice, not self-preservation or historical bias.
7.2. The Ethical Imperative of Epistemic Humility
To prevent regulatory and professional mistakes from being repeated on the next generation, institutions must adopt Epistemic Humility—the recognition that their current “version of science” may be incomplete or flawed.[39] Scientific insights are crucial for informing the normative debate and evaluating existing ethical norms.[40]
The continued legal classification of cannabis as Schedule I despite the definitive scientific validation of the ECS (starting in 1988 and accelerating through 2012) [30] demonstrates a profound failure of Epistemic Humility by regulatory and scientific professionals. The ethical duty following the ECS discovery is to ensure that the regulatory framework (CSA) immediately aligns with scientific reality. Continued adherence to a scientifically refuted premise confirms dogmatism over duty, criminalizing known healing mechanisms and restricting access to potential pain relief, thereby prioritizing legal structure over non-maleficence and beneficence.
7.3. Restorative Justice (RJ) as a Model for Institutional Accountability
Moving past historical mistakes requires shifting from a punitive, defensive framework to a model of Restorative Justice (RJ). RJ emphasizes community connection, accountability, and methods for addressing the systemic and proliferative impact of actions, focusing on healing rather than merely punishing individual lapses.[41]
The need for a “healing perspective” is supported by Congress’s own acknowledgment and apology for the harm inflicted upon communities by the War on Drugs.[42] A restorative professional ethics framework would require:
1. Radical Transparency: Full disclosure of iatrogenic risks and acknowledgement of scientific/regulatory failures (e.g., the scientifically indefensible Schedule I status).
2. Institutional Accountability: Adoption of restorative practices to address systemic harm caused by anticompetitive licensing [15] and scientifically obsolete policies.
3. Occupational Equity: Actively dismantling the “separate but unequal” professional estate to ensure patients have access to diverse, safe, and effective healing options.[12]
4. Plant Equality: If a plant is a plant it is not a drug.
By focusing on Restorative Accountability, medical and legal professions can fulfill their moral mission and ensure that future generations are protected from policies driven by economic interest or outdated scientific dogma, prioritizing patient welfare and autonomy.[38]
VIII. Conclusion: Reconciling Science, Sovereignty, and Healing in the Next Generation
The analysis reveals that the individual’s pursuit of religious exemption from state medical mandates is not an isolated demand but a necessary constitutional defense against a regulatory structure prone to iatrogenic harm and legislative overreach. The demonstrable risk of medical “drug trauma” [3], coupled with the administrative adherence to scientifically discredited prohibitions (cannabis Schedule I) [26, 27], provides the factual predicate for strict scrutiny under RFRA, thereby legitimizing the need for constitutional sanctuary.
The legal consequence for professions that defend this failing system is clear: State licensing boards operating under the color of law face potential liability under 42 U.S.C. § 1983 for enforcing regulations that violate Due Process, suppress professional speech, or promote anticompetitive classifications.[15, 21] Furthermore, the continued enforcement of the CSA’s Schedule I status, contradicting the scientific reality of the Endocannabinoid System [30], represents an administrative failure that directly hinders the constitutional and ethical duty of professionals to seek the least restrictive and most effective path to healing.
While the “War on Drugs” did not require a formal declaration of war by Congress to institute its domestic policy mechanisms (the CSA) [33], the rhetoric of “war” justified an expansion of federal regulatory authority that has since been acknowledged by Congress as a policy failure.[42]
The path forward requires a shift in professional integrity, moving away from regulatory paternalism toward Epistemic Humility and Restorative Accountability. Medical and legal professions must reconcile their standards of care with constitutional mandates and scientific truth, ensuring that the pursuit of justice and health serves to protect individual liberty and facilitate all scientifically supported healing modalities for the next generation. This mandates a fundamental restructuring of professional licensing to promote equity and dismantle structures designed to protect incumbent economic interests rather than patient well-being.
——————————————————————————–
1. When Is Iatrogenic Harm Negligent? | Journal of Ethics | American Medical Association, https://journalofethics.ama-assn.org/article/when-iatrogenic-harm-negligent/2022-08
2. Can Epidural Injuries Be a Claim of Medical Malpractice? – Porter Law Group, https://porterprotects.com/can-epidural-injuries-be-a-claim-of-medical-malpractice/
3. Epidural Errors | Syracuse Medical Malpractice Lawyers DeFrancisco & Falgiatano, LLP, https://www.defranciscolaw.com/epidural-errors.html
4. Medical Ethics and Law – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC10593724/
5. Informed Consent: A Right without a Remedy Examined through the Lens of Maternity Care, https://digitalcommons.wcl.american.edu/cgi/viewcontent.cgi?article=1590&context=jgspl
6. TIMING OF LABOR EPIDURAL INFORMED CONSENT PROCESS PROMOTES PATIENT SAFETY AND UNDERSTANDING – Doctors of Nursing Practice, https://www.doctorsofnursingpractice.org/wp-content/uploads/project_form/complete_200724025905.pdf
7. Protecting Patients from their Bad Decisions: Rebalancing Rights, Relationships, and Risk, https://pmc.ncbi.nlm.nih.gov/articles/PMC5907906/
8. The Religious Freedom Restoration Act: A Primer | Congress.gov, https://www.congress.gov/crs-product/IF11490
9. The Need for a Compelling Interest Test on a State Level – BYU ScholarsArchive, https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?referer=&httpsredir=1&article=1169&context=byuplr
10. Employment Division v. Smith | 494 U.S. 872 (1990) – Justia U.S. Supreme Court Center, https://supreme.justia.com/cases/federal/us/494/872/
11. State Medical Boards, Licensure, and Discipline in the United States – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC7011294/
12. Licensure of Complementary and Alternative Practitioners – AMA Journal of Ethics, https://journalofethics.ama-assn.org/article/licensure-complementary-and-alternative-practitioners/2011-06
13. How does the law recognize and deal with medical errors? – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC2711199/
14. A Way Out of the Maze: Federal Agency Preemption of State Licensing and Regulation of Complementary and Alternative Medicine Practitioners, https://www.cambridge.org/core/journals/american-journal-of-law-and-medicine/article/way-out-of-the-maze-federal-agency-preemption-of-state-licensing-and-regulation-of-complementary-and-alternative-medicine-practitioners/AD1E911D7DD42B13A6D86272670F296D
15. ‘Certificate of Need’ and occupational licensing laws restrict access to healthcare. States can do better. – Pacific Legal Foundation, https://pacificlegal.org/certificate-of-need-and-occupational-licensing-laws-restrict-access-to-healthcare-states-can-do-better/
16. Traditional Equal Protection: Economic Regulation and Related Exercises of the Police Power – Justia Law, https://law.justia.com/constitution/us/amendment-14/07-traditional-equal-protection-economic-regulation.html
17. Professional Speech | Yale Law Journal, https://yalelawjournal.org/article/professional-speech
18. “A “License to Kale”” by Taylor J. Newman and Angela E. Surrett – Digital Commons at St. Mary’s University, https://commons.stmarytx.edu/thestmaryslawjournal/vol52/iss4/1/
19. Lakewood v. Plain Dealer Publ. Co. | 486 U.S. 750 (1988), https://supreme.justia.com/cases/federal/us/486/750/
20. due process | Wex | US Law | LII / Legal Information Institute, https://www.law.cornell.edu/wex/due_process
21. Cases – Liability, civil rights acts – Oyez, https://www.oyez.org/issues/181
22. Title VII of the Civil Rights Act of 1964 | U.S. Equal Employment Opportunity Commission, https://www.eeoc.gov/statutes/title-vii-civil-rights-act-1964
23. commerce clause | Legal Information Institute – Law.Cornell.Edu, https://www.law.cornell.edu/category/keywords/commerce_clause
24. Controlled Substance Act – StatPearls – NCBI Bookshelf – NIH, https://www.ncbi.nlm.nih.gov/books/NBK574544/
25. 21 U.S. Code § 812 – Schedules of controlled substances – Legal Information Institute, https://www.law.cornell.edu/uscode/text/21/812
26. Cannabis and endocannabinoid modulators: Therapeutic promises and challenges – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC2544377/
27. Legalization, Decriminalization & Medicinal Use of Cannabis: A Scientific and Public Health Perspective – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC6181739/
28. Cannabinoids and the endocannabinoid system in the regulation of cytochrome P450 metabolic activity-a review – Frontiers, https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1599012/full
29. History of cannabis and the endocannabinoid system – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC7605027/
30. Endocannabinoid Discovery Timeline – Project CBD, https://projectcbd.org/science/endocannabinoid-research-timeline/
31. The Controlled Substances Act (CSA): A Legal Overview for the 119th Congress, https://www.congress.gov/crs-product/R45948
32. ArtI.S8.C11.2.3 Declarations of War vs. Authorizations for Use of Military Force (AUMF), https://constitution.congress.gov/browse/essay/artI-S8-C11-2-3/ALDE_00013914/
33. Declaration of war by the United States – Wikipedia, https://en.wikipedia.org/wiki/Declaration_of_war_by_the_United_States
34. War on drugs – Wikipedia, https://en.wikipedia.org/wiki/War_on_drugs
35. Trump’s Venezuela boat strikes fuel war crimes allegations. Are they legal?, https://www.cbsnews.com/news/trump-hegseth-venezuela-boat-strikes-war-crimes-are-they-legal/
36. McGovern introduces resolution seeking to prevent war in Venezuela, https://recorder.com/2025/12/03/mcgovern-introduces-resolution-seeking-to-prevent-war-in-venezuela/
37. Medical Ethics – StatPearls – NCBI Bookshelf – NIH, https://www.ncbi.nlm.nih.gov/books/NBK535361/
38. Selective Paternalism | Journal of Ethics | American Medical Association, https://journalofethics.ama-assn.org/article/selective-paternalism/2012-07
39. Ethics: Professionalism, Craft, and Failure – UKnowledge, https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=2058&context=klj
40. Normative Ethics Does Not Need a Foundation: It Needs More Science – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC3068523/
41. Restorative Justice Practices as a Foundation for Medical Education Innovation – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC11663732/
42. H.Res.933 – 115th Congress (2017-2018): To acknowledge that the War on Drugs has been a failed policy in achieving the goal of reducing drug use, and for the House of Representatives to apologize to the individuals and communities that were victimized by this policy., https://www.congress.gov/bill/115th-congress/house-resolution/933/text
